WOIPPY, France–(BUSINESS WIRE)–Regulatory News: ABL Texcell Diagnostics (Euronext Paris: ABLD – ISIN: FR001400AHX6)(“Company”) informs its shareholders and all stakeholders that it has been notified of the notice of appeal filed by the Public Prosecutor attached to the Évry-Courcouronnes Judicial Court against the judgment rendered by the Évry-Courcouronnes Commercial Court on October 9, 2026, approving the offer submitted by the Cmpany for the acquisition of IntegraGen’s assets and business